Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
J&J’s Ethicon Issues Class I Correction For Echelon Stapler Reloads Amid Lockout Risk
More Than 50 Lots Affected As FDA Classifies Correction As Highest-Severity Recall
Aug 05 2025
•
By
Shubham Singh
The correction affects more than 50 product lots. Picture Courtesy: J&J Medtech
More from US FDA Warning Letters
More from Surgery